Amphastar Pharmaceuticals's EBIT per Share for the
three
months ended in Mar. 2024 was $1.07.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $4.14.
During the past 12 months, the average EBIT per Share Growth Rate of Amphastar Pharmaceuticals was 81.30% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 155.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Amphastar Pharmaceuticals's EBIT per Share or its related term are showing as below:
AMPH'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -47.2 Med: 42.6 Max: 155.4
Current: 155.4
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Amphastar Pharmaceuticals was 155.40% per year. The lowest was -47.20% per year. And the median was 42.60% per year.
AMPH's 3-Year EBIT Growth Rate is ranked better than 99.3% of 854
companies
in the Drug Manufacturers industry
Industry Median: 7.7
vs AMPH: 155.40
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.14
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amphastar Pharmaceuticals (NAS:AMPH) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Amphastar Pharmaceuticals EBIT per Share Related Terms
Thank you for viewing the detailed overview of Amphastar Pharmaceuticals's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Amphastar Pharmaceuticals (Amphastar Pharmaceuticals) Business Description
Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AMPH has been successfully added to your 